BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment Using Digital Technology

  Takeda, Lundbeck U.S. and Advocate Health Care today announced a collaboration focusing on the use of digital technology to support people living with depression.

  November 6, 2017

   · 

  6 min read
• Business

  Banner ALZ’s Institute, Novartis, and Amgen Expand Collaboration in Pioneering ALZ’s Prevention Program

  November 6, 2017

   · 

  4 min read
• Biotech Beach

  New GSK Multi-Country Survey Reveals Need for Improved Awareness Around Long-Term Impact and Appropriate Use of Corticosteroids in SLE Management

  Results from EnABLE highlight an opportunity for increased awareness on appropriate corticosteroid use and a more proactive approach to the management of SLE.

  November 6, 2017

   · 

  5 min read
• Business

  CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results

  CombiMatrix reported total revenues for the third quarter of 2017 of $4.0 million, a 23.5% increase from $3.2 million for the third quarter of 2016.

  November 6, 2017

   · 

  16 min read
• Biotech Beach

  Ensysce Biosciences to Present at Human Abuse Liability & Abuse-Deterrent Formulations Conference in Bethesda, Maryland on November 6th and 7th

  The conference will provide information and training to participants on topics such as: preclinical development of abuse-deterrent drugs and delivery mechanisms, clinical trial design, and building strong, reliable networks with every stakeholder throughout the regulatory and market access community.

  November 6, 2017

   · 

  3 min read
• Drug Development

  Novartis Seeks Leadership With Cosentyx Showing No Radiographic Progression in Ankylosing Spondylitis at 4 Years

  The new data also confirm sustained improvement in signs and symptoms in almost 80 percent of patients, while Cosentyx delivers a favorable and consistent safety profile[1].

  November 6, 2017

   · 

  11 min read
• iTeos Therapeutics to Present New Data at Upcoming 2017 SITC Annual Meeting

  iTeos Therapeutics today announced the presentation of posters on its novel A2A receptor antagonist and TIGIT antibody programs, at the upcoming SITC 32nd Annual Meeting, taking place from November 8-12, 2017 in National Harbor, Maryland.

  November 6, 2017

   · 

  3 min read
• Business

  Reata Provides Update on Bardoxolone Methyl from the American Society of Nephrology Kidney Week Meeting

  Conference call to update bardoxolone renal program today at 8:30am ET.

  November 6, 2017

   · 

  6 min read
• Business

  Nuevolution Appoints Johnny Stilou as Director of Investor Relations and Corporate Communication

  Johnny Stilou will join the company as early as possible during the first quarter 2018, but no later than 1 March 2018.

  November 6, 2017

   · 

  2 min read
• Business

  Henry Schein Reports Record 3rd Quarter Financial Results

  All per share figures in this news release reflect the 2-for-1 common stock split that Henry Schein completed during the third quarter of 2017.

  November 6, 2017

   · 

  24 min read